SecSonar.com

TriSalus Life Sciences, Inc. (TLSI)

TriSalus Life Sciences, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

TriSalus Life Sciences, Inc. (TLSI) is a Medical - Devices company based in US with a market capitalization of $128.5M. Revenue grew 53.4% year-over-year and free cash flow was negative at -$18.9M. This page tracks TLSI's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 110 employees · IPO Feb 8, 2021

Valuation

Valuation & price

$2.68 · as of May 17, 2026 · -64.3% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

—

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$7.46$4.99$2.52Jul 25Dec 25Jul 26Jul 7, 25$4.96Jul 9, 25$5.01Jul 11, 25$4.89Jul 15, 25$4.74Jul 17, 25$4.72Jul 21, 25$4.57Jul 23, 25$4.70Jul 25, 25$4.56Jul 29, 25$4.34Jul 31, 25$4.23Aug 4, 25$4.20Aug 6, 25$3.95Aug 11, 25$3.57Aug 13, 25$3.95Aug 15, 25$4.55Aug 19, 25$4.65Aug 21, 25$4.96Aug 25, 25$4.93Aug 27, 25$5.10Aug 29, 25$5.22Sep 3, 25$4.98Sep 5, 25$4.99Sep 9, 25$4.90Sep 11, 25$4.68Sep 16, 25$4.73Sep 18, 25$4.92Sep 22, 25$4.88Sep 24, 25$4.84Sep 26, 25$4.70Sep 30, 25$4.65Oct 2, 25$4.52Oct 6, 25$4.63Oct 8, 25$4.85Oct 10, 25$4.32Oct 14, 25$4.68Oct 16, 25$4.75Oct 21, 25$5.14Oct 23, 25$5.13Oct 27, 25$5.02Oct 29, 25$4.74Oct 31, 25$4.74Nov 4, 25$4.70Nov 6, 25$4.39Nov 10, 25$4.00Nov 12, 25$4.42Nov 14, 25$4.56Nov 18, 25$4.60Nov 20, 25$4.96Nov 25, 25$6.29Nov 28, 25$6.87Dec 2, 25$6.45Dec 4, 25$6.70Dec 8, 25$6.74Dec 10, 25$7.25Dec 12, 25$7.31Dec 16, 25$7.42Dec 18, 25$7.28Dec 22, 25$7.46Dec 24, 25$7.06Dec 29, 25$6.86Jan 2, 26$6.10Jan 6, 26$5.89Jan 8, 26$6.14Jan 12, 26$5.87Jan 14, 26$5.83Jan 16, 26$5.53Jan 21, 26$5.53Jan 23, 26$5.44Jan 27, 26$5.22Jan 29, 26$4.99Feb 2, 26$5.11Feb 4, 26$4.91Feb 9, 26$4.52Feb 11, 26$4.80Feb 13, 26$4.87Feb 18, 26$4.64Feb 20, 26$5.45Feb 24, 26$5.32Feb 26, 26$5.38Mar 2, 26$5.01Mar 4, 26$5.00Mar 6, 26$4.47Mar 10, 26$4.26Mar 12, 26$4.10Mar 17, 26$4.02Mar 19, 26$3.86Mar 23, 26$3.92Mar 25, 26$4.01Mar 27, 26$3.85Mar 31, 26$4.00Apr 2, 26$4.24Apr 7, 26$3.96Apr 9, 26$4.23Apr 13, 26$4.35Apr 15, 26$4.49Apr 17, 26$4.65Apr 22, 26$4.60Apr 24, 26$4.64Apr 28, 26$4.49Apr 30, 26$4.32May 4, 26$4.45May 6, 26$4.55May 8, 26$4.43May 12, 26$4.56May 14, 26$2.52May 18, 26$3.03May 20, 26$3.24May 22, 26$3.26May 28, 26$3.27Jun 1, 26$3.67Jun 3, 26$3.18Jun 5, 26$3.17Jun 9, 26$3.34Jun 11, 26$3.64Jun 15, 26$4.20Jun 17, 26$3.89Jun 22, 26$4.20Jun 24, 26$4.16Jun 26, 26$4.73Jul 2, 26$4.69
$2.5252-week range$7.50
Loading valuation history…

Fundamentals

Key fundamentals

$128.5M

Market cap

53.4%

Revenue growth (YoY)

84.6%

Gross margin

-$18.9M

Free cash flow (USD)

$14M

Net debt

43.0%

Share dilution

0/4

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2020 → 2025

FY 2020$0.00FY 2021$8.4MFY 2022$12.4MFY 2023$18.5MFY 2024$29.4MFY 2025$45.2M
$0$45.2M

Free cash flow by year

2020 → 2025

FY 2020$-677.6KFY 2021$-24.0MFY 2022$-33.1MFY 2023$-51.2MFY 2024$-41.2MFY 2025$-18.9M
-$677.6K-$18.9M

Gross margin by year

2021 → 2025

FY 202185.8%FY 202281.8%FY 202385.9%FY 202486.1%FY 202584.6%
85.8%84.6%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 12, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventAnnual Meeting ResultsMay 14, 2026Filing
  • 8-K eventEarnings ReleaseMay 12, 2026Filing
  • Quarterly report10-Q FiledMay 12, 2026Filing
  • 8-K eventExecutive RetirementApr 29, 2026Filing
  • 8-K eventChief Medical Officer AppointmentApr 7, 2026Filing

Questions

Frequently asked questions

What is TriSalus Life Sciences, Inc.'s market cap?

TriSalus Life Sciences, Inc. (TLSI) has a market capitalization of $128.5M.

What is TLSI's P/E ratio?

A meaningful P/E ratio is not available for TLSI — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

Are insiders buying TLSI stock?

SEC Form 4 filings show no open-market insider buys at TriSalus Life Sciences, Inc. in the last 90 days (0 sells).

Same arena

Related companies in Medical - Devices

HYPR

Hyperfine, Inc.

$133.5M

NNOX

Nano-X Imaging Ltd.

$134.7M

MXCT

MaxCyte, Inc.

$135.5M

QTI

QT Imaging Holdings, Inc.

$136.9M

FONR

FONAR Corporation

$117.6M

SNWV

SANUWAVE Health, Inc.

$143.2M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.